This invention relates to new oxazolidinones having a cyclopropyl moiety, which are effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci,
Bacteroides
spp.,
Clostridia
spp. species, as well as acid-fast organisms such as
Mycobacterium tuberculosis
and other mycobacterial species.
The compounds are represented by structural formula I:
its enantiomer, diastereomer, or pharmaceutically acceptable salt or ester thereof.
本发明涉及一种具有环丙基基团的新型
噁唑烷酮,对需氧和厌氧病原体具有有效作用,如多重耐药葡萄球菌,链球菌和肠球菌,Bacteroides spp.,Clostridiaspp.物种,以及酸性快速
生物如结核分枝杆菌和其他分枝杆菌物种。化合物由结构式I表示:其对映异构体,非对映异构体或其药学上可接受的盐或酯。